Uncategorized Morgan Stanley Lowered the Firm’s PT on Merck & Co (MRK), Kept a Hold Rating Post Content
Uncategorized Jim Cramer Expresses Bullishness on Zimmer’s Acquisition of Monogram Technologies Post Content
Uncategorized Barclays Raised the Firm’s PT on 3M Company (MMM), Kept an Overweight Rating Post Content